Ocifisertib (fumarate)
Product Specifications
Product Name Alternative
CFI-400945 (fumarate)
UNSPSC Description
CFI-400945 fumarate is a potent, selective and orally bioavailable PLK4 inhibitor with a Ki and an IC50 of 0.26 nM and 2.8 nM, respectively.
Target Antigen
Polo-like Kinase (PLK)
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cc_fumarate_.html
Purity
99.44
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
OC(/C=C/C(O)=O)=O.O=C1[C@@]2(C3=CC(OC)=CC=C3N1)[C@H](C4=CC=C(C(/C=C/C5=CC=C(C=C5)CN6C[C@H](O[C@H](C6)C)C)=NN7)C7=C4)C2
Molecular Weight
650.72
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-12300B/Ocifisertib-fumarate-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-12300B/Ocifisertib-fumarate-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
1616420-30-4
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GITR Protein, Human, Recombinant (His & AVI Tag), Biotinylated